Michael Jeffrey Abrams
Founder chez Abdera Therapeutics, Inc.
Profil
Michael Jeffrey Abrams is the founder of AnorMED, Inc. (founded in 1996) and Abdera Therapeutics, Inc. (founded in 2014).
He held the title of President & Chief Executive Officer at AnorMED, Inc. in 2006.
Currently, Dr. Abrams holds the position of Director at The Centre for Drug Research & Development, TRIUMF Innovations, Inc., SaNOtize Research & Development Corp., and the University of British Columbia.
In his former positions, he served as President & Chief Executive Officer at Inimex Pharmaceuticals, Inc. from 2009 to 2012, Executive Chairman at Indel Therapeutics, Inc. from 2008 to 2013, Director at MIGENIX, Inc. from 2006 to 2008, Independent Director at Arbutus Biopharma Corp.
from 2008 to 2016, Director at Protiva Biotherapeutics, Inc. from 2001 to 2008, Independent Director at NervGen Pharma Corp.
from 2018 to 2022, Manager-Worldwide Biomedical Research at Johnson Matthey Plc, and Vice President-Research & Development at CDRD Ventures, Inc. from 2012 to 2013.
Dr. Abrams obtained a doctorate degree from the Massachusetts Institute of Technology in 1983 and an undergraduate degree from Bowdoin College in 1978.
Postes actifs de Michael Jeffrey Abrams
| Sociétés | Poste | Début |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | - |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Director/Board Member | 02/09/2009 |
TRIUMF Innovations, Inc.
 TRIUMF Innovations, Inc. Information Technology ServicesTechnology Services TRIUMF Innovations, Inc. is the business interface and commercialization arm of TRIUMF, Canada's particle accelerator center. The private company is based in Vancouver, Canada. The Canadian company connects TRIUMF to the private sector through industry partnerships, licensing, and company creation. Kathryn Hayashi has been the CEO of the company since 2017. | Director/Board Member | - |
SaNOtize Research & Development Corp.
 SaNOtize Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services SaNOtize Research & Development Corp operates as a biotech company. The firm develops antimicrobial and immunomodulation technology to treat and prevent microbial infections, including drug resistant microbes. The company was founded by Gilly Regev and Chris Miller and is headquartered in Vancouver, Canada. | Director/Board Member | - |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Founder | 01/01/2020 |
Anciens postes connus de Michael Jeffrey Abrams
| Sociétés | Poste | Fin |
|---|---|---|
| NERVGEN PHARMA CORP. | Director/Board Member | 13/04/2022 |
| ARBUTUS BIOPHARMA CORPORATION | Director/Board Member | 16/06/2014 |
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Chairman | 01/01/2013 |
CDRD Ventures, Inc.
 CDRD Ventures, Inc. Pharmaceuticals: MajorHealth Technology CDRD Ventures, Inc. engages in the development and production of therapeutic products. The company is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Jeffrey Abrams
| Massachusetts Institute of Technology | Doctorate Degree |
| Bowdoin College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| JOHNSON MATTHEY PLC | Process Industries |
| NERVGEN PHARMA CORP. | Health Technology |
| Entreprise privées | 10 |
|---|---|
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Inimex Pharmaceuticals, Inc.
 Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Health Technology |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Commercial Services |
CDRD Ventures, Inc.
CDRD Ventures, Inc. Pharmaceuticals: MajorHealth Technology CDRD Ventures, Inc. engages in the development and production of therapeutic products. The company is headquartered in Vancouver, Canada. | Health Technology |
TRIUMF Innovations, Inc.
TRIUMF Innovations, Inc. Information Technology ServicesTechnology Services TRIUMF Innovations, Inc. is the business interface and commercialization arm of TRIUMF, Canada's particle accelerator center. The private company is based in Vancouver, Canada. The Canadian company connects TRIUMF to the private sector through industry partnerships, licensing, and company creation. Kathryn Hayashi has been the CEO of the company since 2017. | Technology Services |
SaNOtize Research & Development Corp.
SaNOtize Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services SaNOtize Research & Development Corp operates as a biotech company. The firm develops antimicrobial and immunomodulation technology to treat and prevent microbial infections, including drug resistant microbes. The company was founded by Gilly Regev and Chris Miller and is headquartered in Vancouver, Canada. | Commercial Services |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Health Technology |
